imCORE (immunotherapy Centers Of Research Excellence) is the leading academic-industry partnership in cancer immunotherapy (CIT). Led by Roche Genentech, it is a global network of leading scientific and clinical experts from 27 of the world’s leading research centres in CIT.   The members collaborate on existing and new investigational medicines, innovative diagnostic technologies and emerging data. The imCORE members are united by the same common goal: to accelerate and advance research in cancer immunotherapy to find a cure and transform patient lives.

imCORE is about building true partnerships, that leverage the collective resources, expertise and cutting-edge technologies, to achieve the vision of together advancing and accelerating cancer immunotherapy research and development to transform cancer treatment for patients